Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
«
»
9 Hits
Search Condition : Filter (MeSH = Fusion Proteins, bcr-abl / metabolism*)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
K562
60001
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
Int J Oncol
2019-5-1
Pubmed
Full text
Human and Animal Cells
Ba/F3-CL1(RCB4474)
59858
Localization of BCR-ABL to Stress Granules Contributes to Its Oncogenic Function.
Cell Struct Funct
2019-12-26
Pubmed
Full text
Human and Animal Cells
Ba/F3(RCB0805)
55945
Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation.
Biochem Pharmacol
2018-8-1
Pubmed
Full text
Human and Animal Cells
44754
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.
PLoS One
2013-1-1
Pubmed
Full text
Human and Animal Cells
44196
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells.
Int J Oncol
2013-2-1
Pubmed
Full text
Human and Animal Cells
41479
Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells.
J Biol Chem
2002-3-8
Pubmed
Full text
Human and Animal Cells
38228
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.
Apoptosis
2010-5-1
Pubmed
Full text
Human and Animal Cells
37809
The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells.
Leuk Res
2009-7-1
Pubmed
Full text
Mice
B6.Cg-Tg(Tec-p210 BCR/ABL1)1Homy(RBRC02339)
30500
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
Clin Cancer Res
2014-8-1
Pubmed
Full text